Signal transduction by vascular endothelial growth factor receptors
Top Cited Papers
- 28 June 2011
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 437 (2), 169-183
- https://doi.org/10.1042/bj20110301
Abstract
VEGFs (vascular endothelial growth factors) control vascular development during embryogenesis and the function of blood vessels and lymphatic vessels in the adult. There are five related mammalian ligands, which act through three receptor tyrosine kinases. Signalling is modulated through neuropilins, which act as VEGF co-receptors. Heparan sulfate and integrins are also important modulators of VEGF signalling. Therapeutic agents that interfere with VEGF signalling have been developed with the aim of decreasing angiogenesis in diseases that involve tissue growth and inflammation, such as cancer. The present review will outline the current understanding and consequent biology of VEGF receptor signalling.Keywords
This publication has 190 references indexed in Scilit:
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- VEGF Receptor 2 Endocytic Trafficking Regulates Arterial MorphogenesisDevelopmental Cell, 2010
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapyCancer Letters, 2008
- Vascular permeability, vascular hyperpermeability and angiogenesisAngiogenesis, 2008
- Autocrine VEGF Signaling Is Required for Vascular HomeostasisCell, 2007
- Dimerization of VEGF receptors and implications for signal transduction: A computational studyBiophysical Chemistry, 2007
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995